T. Vermassen

发表

Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents

N. Lumen, S. Rottey, J. Delanghe, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Usefulness of indirect alcohol biomarkers for predicting recidivism of drunk-driving among previously convicted drunk-driving offenders: results from the recidivism of alcohol-impaired driving (ROAD) study.

M. D. De Buyzere, J. Delanghe, T. Maenhout, 2014, Addiction.

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer

D. Laukens, J. Van Dorpe, S. Rottey, 2017, Oncotarget.

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?

S. Rottey, H. Vlierberghe, T. Kerre, 2021, Immunotherapy.

To treat or not to treat? Managing comorbidities in cancer patients under immune checkpoint inhibition

S. Rottey, K. Vermaelen, V. Kruse, 2020, Acta clinica Belgica.

Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.

S. Rottey, S. Aspeslagh, F. Duprez, 2017, Pathology.

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

P. Pauwels, S. Rottey, F. Duprez, 2021, Clinical and translational science.

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium

J. Machiels, N. Lumen, P. Debruyne, 2014, Acta clinica Belgica.

Concordance, Correlation, and Clinical Impact of Standardized PD-L1 and TIL Scoring in SCCHN

S. Rottey, F. Duprez, D. Creytens, 2022, Cancers.

Tissue N-linked glycosylation as potential prognostic biomarker for biochemical recurrence-free survival

N. Callewaert, N. Lumen, S. Rottey, 2021, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?

S. Rottey, H. Vermeersch, T. Vermassen, 2022, International journal of molecular sciences.

Prognostic Features of Near-Infrared Spectroscopy Following Primary Radical Prostatectomy

N. Lumen, S. Rottey, J. Delanghe, 2021, Cancers.

Glycosylation of prostate specific antigen and its potential diagnostic applications.

N. Lumen, S. Rottey, M. Speeckaert, 2012, Clinica chimica acta; international journal of clinical chemistry.

Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile

N. Callewaert, N. Lumen, K. Decaestecker, 2017, Journal of Clinical Pathology.

Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?

A. Mäkitie, S. Rottey, I. Leivo, 2022, Cancers.

Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma

M. V. D. Walle, S. Rottey, T. Vermassen, 2017, Acta clinica Belgica.

Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives

S. Rottey, D. Creytens, L. Ferdinande, 2021, Cancers.

Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck.

S. Rottey, S. Aspeslagh, W. Huvenne, 2017, Oral oncology.

Importance of choice of materials and methods in PD‐L1 and TIL assessment in oropharyngeal squamous cell carcinoma

S. Rottey, S. Aspeslagh, F. Duprez, 2018, Histopathology.

TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?

S. Rottey, S. Aspeslagh, K. Vandecasteele, 2017, Head and Neck Pathology.

Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies

A. Awada, P. Barthélémy, T. Gil, 2019, AntiCancer Research.

Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis

N. Lumen, K. Decaestecker, S. Rottey, 2015, Biochemia medica.

Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.

S. Rottey, F. Duprez, D. Creytens, 2021, Pathology.

N-Linked Glycosylation and Near-Infrared Spectroscopy in the Diagnosis of Prostate Cancer

N. Callewaert, N. Lumen, S. Rottey, 2019, International journal of molecular sciences.

Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer

N. Callewaert, N. Lumen, K. Decaestecker, 2015, The Prostate.

Urinary Prostate Protein Glycosylation Prof|ling asaDiagnosticBiomarker forProstateCancer

N. Callewaert, N. Lumen, K. Decaestecker, 2014 .

Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer

N. Callewaert, N. Lumen, S. Rottey, 2014, Electrophoresis.

A Tissue Section-Based Near-Infrared Spectroscopical Analysis of Salivary Gland Tumors

M. Speeckaert, J. Delanghe, H. Vermeersch, 2021, Cancers.

CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck

S. Rottey, S. Aspeslagh, F. Duprez, 2016, Pathobiology.

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer.

D. Laukens, S. Rottey, S. Aspeslagh, 2017, Oncotarget.

The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer

N. Lumen, J. Delanghe, C. Van Praet, 2024, Biomedicines.

Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients

N. Lumen, J. Delanghe, C. Van Praet, 2024, Clinical kidney journal.

Prostate Protein N-Glycosylation Profiling by Means of DNA Sequencer-Assisted Fluorophore-Assisted Carbohydrate Electrophoresis.

N. Callewaert, S. Rottey, J. Delanghe, 2019, Methods in molecular biology.